Genius Group to Host Virtual Roadshow Webinar on Tuesday, June 18th at 11:00 a.m. Eastern Time
Management to Present an Overview of the Business Model and Discuss Recent Milestone Achievements SINGAPORE, June 04, 2024 (GLOBE NEWSWIRE) […]
Occidental and BHE Renewables Form Joint Venture to Commercialize TerraLithium Extraction Technology
HOUSTON , June 04, 2024 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) and BHE Renewables, a wholly owned subsidiary of Berkshire […]
Galectin Therapeutics to Present at the European Association for the Study of the Liver (EASL) 2024 Congress
NORCROSS, Ga., June 04, 2024 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin-3, today […]
iCAD to Participate in the MedInvest MedTech, AI & Digital Health Conference
NASHUA, N.H., June 04, 2024 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create […]
Amarin Board of Directors Announces CEO Transition
— Board Appoints Aaron Berg as President & CEO — — Patrick Holt to Step Down as President & CEO […]
Midland and SOQUEM Launch Their 2024 Exploration Campaign in the Labrador Trough, Quebec
MONTREAL, June 04, 2024 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce its summer 2024 exploration […]
Hubbell Hosts 2024 Investor Day
Shelton, CT, June 04, 2024 (GLOBE NEWSWIRE) — Hubbell Incorporated (NYSE: HUBB) is hosting its 2024 Investor Day today at the […]
Bread Financial™ to Host Investor Day on June 18
COLUMBUS, Ohio, June 04, 2024 (GLOBE NEWSWIRE) — Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that […]
TSX News -
Microbix Advances Test-Ingredient Manufacturing Capabilities
MISSISSAUGA, Ontario, June 04, 2024 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, […]
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blocking Antibody ANX005 in Guillain-Barré Syndrome
Single Infusion of ANX005 30 mg/kg Met Primary Endpoint, Delivering a Highly Statistically Significant and Clinically Meaningful 2.4-fold Improvement in […]
